Virtus Biotech ETF (BBP)

Assets	$91.50M
Expense Ratio	0.34%
PE Ratio	n/a
Shares Out	1.00M
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	5,431
Open	97.84
Previous Close	98.20
Day's Range	96.61 - 98.05
52-Week Low	60.91
52-Week High	105.21
Beta	0.55
Holdings	70
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

18.52% of assets

Name	Symbol	Weight
Crinetics Pharmaceuticals, Inc.	CRNX	3.12%
Agios Pharmaceuticals, Inc.	AGIO	1.80%
Ultragenyx Pharmaceutical Inc.	RARE	1.79%
Moderna, Inc.	MRNA	1.76%
Verastem, Inc.	VSTM	1.74%
Geron Corporation	GERN	1.68%
Rigel Pharmaceuticals, Inc.	RIGL	1.67%
Syndax Pharmaceuticals, Inc.	SNDX	1.67%
BridgeBio Pharma, Inc.	BBIO	1.66%
Kura Oncology, Inc.	KURA	1.63%

Performance

BBP had a total return of 58.88% in the past year, including dividends. Since the fund's inception, the average annual return has been 12.03%.

Data Sources: S&P Global Market Intelligence, CBOE, and more

Historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP. Several fund data points are also provided by Finnhub.

Last checked:

Jul 17, 2026

Data Sources Report a data error